Online citations, reference lists, and bibliographies.
← Back to Search

Type Beta Transforming Growth Factor Is The Primary Differentiation-inducing Serum Factor For Normal Human Bronchial Epithelial Cells.

T. Masui, L. Wakefield, J. Lechner, M. Laveck, M. Sporn, C. Harris
Published 1986 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Type beta transforming growth factor (TGF-beta) was shown to be the serum factor responsible for inducing normal human bronchial epithelial (NHBE) cells to undergo squamous differentiation. NHBE cells were shown to have high-affinity receptors for TGF-beta. TGF-beta induced the following markers of terminal squamous differentiation in NHBE cells: (i) increase in Ca ionophore-induced formation of crosslinked envelopes; (ii) increase in extracellular activity of plasminogen activator; (iii) irreversible inhibition of DNA synthesis; (iv) decrease in clonal growth rate; and (v) increase in cell surface area. The IgG fraction of anti-TGF-beta antiserum prevented both the inhibition of DNA synthesis and the induction of differentiation by either TGF-beta or whole blood-derived serum. Therefore, TGF-beta is the primary differentiation-inducing factor in serum for NHBE cells. In contrast, TGF-beta did not inhibit DNA synthesis of human lung carcinoma cells even though the cells possess comparable numbers of TGF-beta receptors with similar affinities for the factor. Epinephrine antagonized the TGF-beta-induced inhibition of DNA synthesis and squamous differentiation of NHBE cells. Although epinephrine increased the cyclic AMP levels in NHBE cells, TGF-beta did not alter the intracellular level in NHBE cells in either the presence or absence of epinephrine. Therefore, epinephrine and TGF-beta appear to affect different intracellular pathways that control growth and differentiation processes of NHBE cells.
This paper references
10.1016/0092-8674(76)90033-7
Differentiation of the epidermal keratinocyte in cell culture: Formation of the cornified envelope
T. Sun (1976)
10.1038/258487A0
Control of growth of mammalian cells in cell culture
R. Holley (1975)
10.1002/JCP.1040970312
Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor
C. Scher (1978)
10.1016/0092-8674(85)90304-6
Functional homology of mammalian and yeast RAS genes
T. Kataoka (1985)
10.1002/JCP.1041000314
Application of the principles of enzyme kinetics to clonal growth rate assays: An approach for delineating interactions among growth promoting agents
J. Lechner (1979)
10.1002/JCP.1041210106
Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum‐free medium: Clonal analyses, growth kinetics, and cell cycle studies
J. Wille (1984)
10.1016/0014-4827(79)90550-0
Differential effects of cAMP and cGMP on in vitro epidermal cell growth.
C. Marcelo (1979)
Neoplastic transformation and defective control of cell proliferation and differentiation.
J. Wille (1982)
10.1038/310644A0
Comparative biochemical properties of normal and activated human ras p21 protein
J. McGrath (1984)
10.1073/PNAS.82.1.119
Type beta transforming growth factor: a bifunctional regulator of cellular growth.
A. Roberts (1985)
10.1073/PNAS.80.12.3676
Purification and initial characterization of a type beta transforming growth factor from human placenta.
C. Frolik (1983)
10.1016/s0021-9258(18)32345-7
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
R. Assoian (1983)
10.1016/0092-8674(85)90305-8
In yeast, RAS proteins are controlling elements of adenylate cyclase
T. Toda (1985)
10.1038/293072A0
Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis
S. Yuspa (1981)
10.1038/309804A0
Cellular transformation by coordinated action of three peptide growth factors from human platelets
R. Assoian (1984)
10.1016/0022-1759(78)90259-4
Use of staphylococcal protein A as an immunological reagent.
J. Goding (1978)
10.1002/JCP.1041240206
Relationship of ornithine decarboxylase activity and cAMP metabolism to proliferation of normal human bronchial epithelial cells
J. Willey (1985)
Differentiation of normal and malignant cells.
G. B. Pierce (1970)
10.1073/PNAS.82.9.2995
An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases.
R. E. Scott (1985)
10.1126/SCIENCE.6320373
Rat transforming growth factor type 1: structure and relation to epidermal growth factor.
H. Marquardt (1984)
10.1083/JCB.96.3.679
Interactions between the receptors for platelet-derived growth factor and epidermal growth factor
D. Bowen-Pope (1983)
10.1073/PNAS.81.21.6757
Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
R. Tucker (1984)
10.1093/CARCIN/1.8.635
Differential properties among clones of simian virus 40-transformed human epithelial cells.
M. Kaighn (1980)
10.1111/J.1432-0436.1984.TB01361.X
Induction of squamous differentiation of normal human bronchial epithelial cells by small amounts of serum.
J. Lechner (1984)
10.1016/0092-8674(80)90373-6
Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes
J. Rheinwald (1980)
10.1073/PNAS.80.20.6264
Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
M. Anzano (1983)
10.1073/PNAS.79.3.845
Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD.
R. E. Scott (1982)
Differential effects of 12-O-tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells.
J. Willey (1984)
10.1073/PNAS.80.18.5627
Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.
G. Carpenter (1983)
10.1016/0092-8674(77)90058-7
Terminal differentiation of cultured human epidermal cells
H. Green (1977)
10.1021/BI00294A002
Purification and properties of a type beta transforming growth factor from bovine kidney.
A. Roberts (1983)
10.1126/SCIENCE.3975607
Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene.
G. Yoakum (1985)
10.1111/1523-1747.EP12534464
Plasminogen activator in differentiating mouse keratinocytes.
R. Isseroff (1983)
10.1093/CARCIN/5.2.209
Acute effects of 12-O-tetradecanoylphorbol-13-acetate, teleocidin B, or 2,3,7,8-tetrachlorodibenzo-p-dioxin on cultured normal human bronchial epithelial cells.
J. Willey (1984)
10.1016/0092-8674(78)90265-9
Cyclic AMP in relation to proliferation of the Epidermal cell: a new view
H. Green (1978)
10.1126/SCIENCE.6093254
Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.
R. Tucker (1984)
Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.
J. Harper (1975)
10.1016/0092-8674(84)90336-2
G proteins and dual control of adenylate cyclase
A. Gilman (1984)
10.1073/PNAS.79.17.5312
Serum contains a platelet-derived transforming growth factor.
C. B. Childs (1982)
10.1038/295417A0
Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF
A. Roberts (1982)
10.1016/0092-8674(79)90123-5
Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: Activation of the cross-linking by calcium ions
R. Rice (1979)
10.1073/PNAS.78.9.5339
New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.
A. Roberts (1981)
Transforming growth factors from neoplastic and nonneoplastic tissues.
A. Roberts (1983)
Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts.
C. Frolik (1984)
10.1016/0092-8674(84)90071-0
Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts
R. Assoian (1984)
10.1073/PNAS.82.2.376
Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.
V. Manne (1985)
10.1002/JCP.1041100210
Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture
J. A. Proper (1982)
10.1126/SCIENCE.6436980
Homologies between signal transducing G proteins and ras gene products.
J. Hurley (1984)
10.1073/PNAS.75.8.4001
Growth factors from murine sarcoma virus-transformed cells.
J. D. De Larco (1978)
Differential control by platelet factors of squamous differentiation in normal and malignant human bronchial epithelial cells.
J. Lechner (1983)



This paper is referenced by
10.1002/term.2240
Proprotein convertase inhibition promotes ciliated cell differentiation – a potential mechanism for the inhibition of Notch1 signalling by decanoyl‐RVKR‐chloromethylketone
Sangnam Lee (2017)
Growth factors and growth factor malignancies, with special reference a review receptors in human to human lung cancer:
L. Dam (1989)
10.1159/000016850
Recent Developments in the Molecular Characterization of Barrett’s Esophagus
R. Fitzgerald (1998)
C/EBP transcription factors in lung cellular differentiation and development
T. Berg (2005)
Alterations in Tgf-β Signaling Mediate the Biologic Behaviour of Osteosarcoma Cell Lines
Benjamin M. Deheshi (2010)
Factor de crecimiento transformante beta-1: estructura, función y mecanismos de regulación en cáncer
Ó. Zaragoza (2001)
10.1074/JBC.273.12.7066
All-trans-Retinoic Acid Inhibits Jun N-terminal Kinase-dependent Signaling Pathways*
H. Lee (1998)
10.1165/AJRCMB.12.2.7532419
Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro.
M. Shiratori (1995)
10.1164/ajrccm/141.3.765
Cytokines of the lung.
J. Kelley (1990)
10.1016/0304-419X(87)90007-2
Subversion of growth regulatory pathways in malignant transformation.
C. Heldin (1987)
10.1083/JCB.103.5.1799
Regulation of myogenic differentiation by type beta transforming growth factor
E. Olson (1986)
10.1083/JCB.105.1.457
Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro
P. Robey (1987)
10.1165/AJRCMB/5.6.548
Regulation of bovine bronchial epithelial cell proliferation and proto-oncogene expression by growth factors.
H. Takizawa (1991)
[Transforming growth factor beta-1: structure, function, and regulation mechanisms in cancer].
O. Peralta-Zaragoza (2001)
10.1071/RD05163
Role of platelet-derived growth factor-B, vascular endothelial growth factor, insulin-like growth factor-II, mitogen-activated protein kinase and transforming growth factor-beta1 in expansion-induced lung growth in fetal sheep.
M. Wallace (2006)
10.4414/smw.2013.13758
Nanomaterials and the human lung: what is known and what must be deciphered to realise their potential advantages?
C. Jud (2013)
10.1016/0309-1651(86)90102-5
Divergent action of transforming growth factor beta on DNA synthesis in human foetal liver cells.
A. Strain (1986)
Effects of transforming growth factor-beta released from gastric carcinoma cells on the contraction of collagen-matrix gels containing fibroblasts.
H. Ura (1991)
10.1002/JCP.1041440110
Ras and neu oncogenes reverse serum inhibition and epidermal growth factor dependence of serum‐free mouse embryo cells
S. Shirahata (1990)
10.1183/09031936.96.09122501
Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lung.
R. Coker (1996)
10.1007/978-1-4757-9640-7_26
The Wound Response as a Key Element for an Understanding of Multistage Carcinogenesis in Skin
F. Marks (1988)
10.1590/S0036-36342001000400011
Factor de crecimiento transformante beta-1: estructura, función y mecanismos de regulación en cáncer
Ó. Peralta-Zaragoza (2001)
10.1080/000164801300006317
Human respiratory cells from nasal polyps as a model for gene transfer by non-viral cationic vectors.
G. Sersale (2001)
Expression of transforming growth factor-beta in wound healing of vitamin A-deficient rat corneas.
K. Hayashi (1989)
10.1007/978-3-642-84881-0_2
Transforming growth factor regulation of keratinocyte growth.
L. Dagnino (1993)
10.1016/j.currproblcancer.2020.100617
Altered expression of TGF-β1 and TGF-βR2 in tissue samples compared to blood is associated with food habits and survival in esophageal squamous cell carcinoma.
Jayasree Talukdar (2020)
10.1371/journal.pone.0008248
Sox2 Is Required for Maintenance and Differentiation of Bronchiolar Clara, Ciliated, and Goblet Cells
David H. Tompkins (2009)
10.1002/JCP.1041430319
Differential effects of transforming growth factor‐β and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes
D. Vivien (1990)
10.1016/0002-9378(91)90428-T
Transforming growth factor-β1 expression during placental development
L. J. Dungy (1991)
Growth of Poorly and Highly Metastatic Murine Melanoma Cells 1 on the β Differential Effects of Transforming Growth Factor Updated
D. Mooradian (1990)
10.1002/JCB.240390104
Regulation of epithelial cell proliferation by transforming growth factors
C. Bascom (1989)
10.1111/j.1749-6632.1990.tb16117.x
The Role of TGFβ in Mouse Development a
R. Akhurst (1990)
See more
Semantic Scholar Logo Some data provided by SemanticScholar